NCT00501579View on ClinicalTrials.gov

Study of Difluprednate in the Treatment of Uveitis

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

Uveitis

Interventions

DRUG

Difluprednate

DRUG

Prednisolone Acetate

Trial Locations (1)

47150

John-Kenyon American Eye Institute, New Albany

All Listed Sponsors

lead

Sirion Therapeutics, Inc.

INDUSTRY

NCT00501579 - Study of Difluprednate in the Treatment of Uveitis | Biotech Hunter | Biotech Hunter